MARKET

RDY

RDY

Dr Reddys Labs
NYSE
14.44
-0.20
-1.33%
Opening 12:39 07/08 EDT
OPEN
14.39
PREV CLOSE
14.63
HIGH
14.48
LOW
14.39
VOLUME
714.63K
TURNOVER
--
52 WEEK HIGH
15.67
52 WEEK LOW
12.19
MARKET CAP
12.05B
P/E (TTM)
26.24
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RDY last week (0629-0703)?
Weekly Report · 2d ago
Coya Therapeutics posts investor deck outlining Treg-directed combination therapy strategy for neurodegenerative diseases
PUBT · 07/01 12:50
Full Transcript: Dr Reddy's Laboratories Q4 2026 Earnings Call
Benzinga · 07/01 08:20
Monday's ETF Movers: BUG, EMEQ
NASDAQ · 06/29 16:01
Weekly Report: what happened at RDY last week (0622-0626)?
Weekly Report · 06/29 10:06
BUZZ-India's Dr Reddy's rises as analysts project no material impact from US FDA observations
Reuters · 06/29 04:20
Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F
Barchart · 06/26 10:10
BUZZ-Indian pharma stocks gain on US cancer drug shortage
Reuters · 06/25 05:41
More
About RDY
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Webull offers Dr Reddy's Laboratories Ltd (ADR) stock information, including NYSE: RDY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDY stock methods without spending real money on the virtual paper trading platform.